Skip to main content
Subscribe
  • Sign Up Free
  • Login
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Blogs
    • AI
    • Deals
    • Layoff Tracker
    • HIMSS 2023
  • Opinion
    • Breaking Bias
    • Commentaries
    • Letters
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Digital Health Transformation Summit
    • ESG: The Implementation Imperative Summit
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Hospital at Home
    • - Workplace of the Future
    • - AI and Digital Health
    • - Future of Staffing
    • - Hospital of the Future (Fall)
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Sponsored Video Series - One on One
    • Sponsored Video Series - Checking In with Dan Peres
  • Data & Insights
    • Data & Insights Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Insurance
January 30, 2013 11:00 PM

Judge restricts generic drug company from making, distributing drugs

Judy Greenwald, Crain's Business Insurance
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print

    A federal judge has approved a permanent injunction restricting a generic drug company from manufacturing and distributing certain drugs until it complies with the law, the Justice Department said Thursday.

    The DOJ said the company, Ben Venue Laboratories, has been the subject of about 40 recalls since 2002, including 10 each in 2011 and 2012.

    The Bedford, Ohio, company is a subsidiary of Ingelheim, German-based Boehringer Ingelheim.

    The DOJ, which sought the injunction at the Food and Drug Administration's request, said Ben Venue manufactures generic sterile injectible drug products, including cancer medications. According to the agency's Jan. 22 complaint, a November-December 2011 inspection documented 10 deviations from good manufacturing practices, and the findings were similar to several previous inspections at Ben Venue's facility.

    Company's failures

    According to the complaint, the FDA found during the 2011 inspection that the company failed to create and follow appropriate procedures to prevent contamination of drugs that were purported to be sterile.

    It found that the company failed to properly clean and maintain its equipment to ensure the safety and quality of the drugs it manufactured, and that it failed to conduct adequate investigations of drugs that did not meet their specifications.

    The DOJ said some of the recalls involved drugs contaminated with glass and other particulates, while additional recalls were based on the company's inability to assure the drugs' sterility.

    In addition to the company, the consent decree including the permanent injunction named George P. Doyle, the company's president and CEO; Kimberly A. Kellerman, its vice president of operations; and Douglas A. Rich, vice president of quality operations.

    Wide range of actions required

    The consent decree approved by U.S. District Court Judge Lesley Wells requires Ben Venue to take a wide range of actions to correct its violations and ensure they do not happen again, the DOJ said in a statement. It establishes a series of steps that must occur before Ben Venue can fully resume operations, including retaining an expert to inspect the company's facility, developing and implementing a remediation plan, and the FDA inspecting the site to confirm that the company's manufacturing processes fully comply with the law.

    The DOJ said the company is permitted to continue to manufacture and distribute a number of its drugs that the FDA has determined are in shortage or vulnerable to shortage. However, prior to distribution of each batch, the company's expert must certify that no deviations occurred during the manufacturing that would adversely affect their safety or quality.

    “This resolution comes following nearly three dozen inspections which revealed inadequate quality control, including contaminated drugs and led to approximately 40 recalls on products from this facility alone,” said Steven M. Dettelbach, U.S. attorney for the Northern District of Ohio. “The Justice Department and the Food and Drug Administration will continue to place its highest priority on protecting consumers.”

    Company's statement

    In a statement released the same day the complaint was filed, the company said it is “permitted to continue to manufacture and distribute more than 100 important drugs that are essential for patient care and to continue its drug-development activities.

    “To date, Ben Venue has invested more than $300 million to upgrade its facilities, making necessary improvements and changes to processes to address the manufacturing-related issues that have resulted in the company's decision to voluntarily halt manufacturing in November 2011,” according to the statement. “Ben Venue has demonstrated progress in improving manufacturing processes, and announced in October 2012 that limited production had resumed. Since that time, production has resumed on additional manufacturing lines.

    “Ben Venue, in partnership with the FDA, is committed to addressing drug shortage and ensuring critical medicines reach the people who need them. We continue to work closely with the FDA and share the goal of returning to production to manufacture safe and effective medicines.”

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    UnitedHealthcare_i_i_i_i copy_i.png
    UnitedHealth to scrap some Medicare Advantage plans
    US sort term insurance
    States resist Biden proposal limiting short-term health insurance
    Most Popular
    1
    CMS tries luring providers to revamped Medicare ACOs
    2
    Oregon joins other states in setting ratios for nurse staffing
    3
    Blue Shield CA taps Amazon, Mark Cuban, CVS for new PBM model
    4
    A health innovation hub grows in Lake Nona Medical City
    5
    Hospital-at-home providers push for Medicaid coverage
    Sponsored Content
    Daily Finance Newsletter: Sign up to receive daily news and data that has a direct impact on the business and financing of healthcare.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Help Center
    • Advertise with Us
    • Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Blogs
      • AI
      • Deals
      • Layoff Tracker
      • HIMSS 2023
    • Opinion
      • Breaking Bias
      • Commentaries
      • Letters
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Digital Health Transformation Summit
        • ESG: The Implementation Imperative Summit
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Hospital at Home
        • - Workplace of the Future
        • - AI and Digital Health
        • - Future of Staffing
        • - Hospital of the Future (Fall)
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Sponsored Video Series - One on One
      • Sponsored Video Series - Checking In with Dan Peres
    • Data & Insights
      • Data & Insights Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing